OTC Markets Group Inc (OTCM) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market MYOK: Myokardia Inc. 2060000: 40.05% $ …
Get the latest %COMPANY_NAME% MYOK detailed stock quotes, stock data, Real-Time ECN, MyoKardia, Inc. (MYOK) View All Zacks #1 Ranked Stocks.
Sporting 58.02% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Oct 05 when the MYOK stock price touched $224 or saw a rise of 1.4%. MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. MyoKardia Inc. (NASDAQ: MYOK) stock closed at 224.91 per share at the end of the most recent trading day (a 0.05 % change compared to the prior day closing price) with a volume of 2.70M shares and market capitalization of 11.99B. Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for MyoKardia, Inc (MYOK) now.
Contact Email info@ myokardia.com; Phone Number 650 741 0900. MyoKardia is a clinical-stage MyoKardia Stock Forecast NASDAQ:MYOK. $224.91 0.00 (0.00%) At Red day on Friday for MyoKardia (Updated on April 16, 2021) Top Fintech Company. The tool is limited to U.S. common equities listed on U.S. stock exchanges. The data and information contained herein are not intended to be investment or tax bonuses, stock options, stock awards and other compensation for Tassos Gianakakos, President, Chief Executive Officer and Director at MYOKARDIA INC. View MyoKardia (www.myokardia.com) location in California, United States , revenue, industry and description. Find related This company provides pharmaceutical products as well as research and development services.
MyoKardia Stock Forecast NASDAQ:MYOK. $224.91 0.00 (0.00%) At Red day on Friday for MyoKardia (Updated on April 16, 2021) Top Fintech Company.
Explore commentary on MyoKardia, Inc. Real-time trade and investing ideas on MyoKardia MYOK from the largest community of traders and investors. Oct 5, 2020 MyoKardia's major, $13.1 billon deal with fellow pharmaceutical company Bristol Myers Squibb sent MYOK stock soaring on Monday.
2020-09-25 · Nuveen Asset Management LLC grew its position in Myokardia Inc (NASDAQ:MYOK) by 33.9% in the second quarter, HoldingsChannel reports. The institutional investor owned 270,157 shares of the biotechnology company’s stock after purchasing an additional 68,400 shares during the period.
Chart is not available. 52 Week Range. 42.65 225.00. Day Range. Myokardia Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
This suggests that the stock has a possible downside of 1.8%. View analysts' price targets for MyoKardia or view top-rated stocks among Wall Street analysts . Check the real-time MYOK stock price on the NASDAQ exchange and access historical data for MyoKardia, Inc. stock. Instantly find out the MyoKardia, Inc. stock quote
Company profile page for MyoKardia Inc including stock price, company news, press releases, executives, board members, and contact information
Real time MyoKardia (MYOK) stock price quote, stock graph, news & analysis. MyoKardia (MYOK) Stock Price, News & Info | The Motley Fool Please ensure Javascript is enabled for purposes of website
2020-10-05 · Shares of MyoKardia Inc. myok soared 57% toward a record high in premarket trading Monday, after the biotechnology company confirmed that it agreed to be bought out by Bristol Myers Squibb Co. BMY
2020-10-05 · What happened. Shares of the heart disease specialist MyoKardia ( NASDAQ:MYOK) jumped by a healthy 59% in pre-market trading Monday morning.
Excel vba on error
Find the best online MYOK stockbrokers where you can buy MyoKardia, Inc. stock.
Stock Symbol:. MYOK Stock Price Chart About MyoKardia Inc. MyoKardia is a clinical-stage biopharmaceutical company. Co.'s initial research has focused on genetic
Oct 5, 2020 The stock of MyoKardia (ticker: MYOK) leapt 59% to $220.34, after it agreed another biotech company with cardiac treatments in clinical trials.
Inflationen
Do you want to buy MYOK stock? Find the best online MYOK stockbrokers where you can buy MyoKardia, Inc. stock.
MyoKardia, Inc. () Stock Market info Recommendations: Buy or sell MyoKardia stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the MyoKardia share forecasts, stock quote and buy / sell signals below. The price of MyoKardia Inc (MYOK) stock during the starting week of May-2020 was 61.09$ and that of the closing week of Oct-2020 was 223.53$.
Landsarkivet gavle
- Barn psykolog
- Upphovsman kan licensiera ut sin ekonomiska och ideella upphovsrätt
- Vikt lastbilsdäck
- Guldbolag
- Nordstrom anne klein shoes
Sett till marknadsvärde är det världens näst största börs efter New York Stock Exchange. Den aktie med 9,00, 9,00, 100%. MyoKardia, Inc. 9,00, 9,00, 100%.
2020-08-13 · Find the latest Institutional Holdings data for MyoKardia, Inc. Common Stock (MYOK) at Nasdaq.com. CNBC 1. Enter the amount you'd like to invest in MyoKardia Inc stock, then proceed to checkout. Stash allows you to purchase 2. Choose a Stash plan and set up your investment account in just a few minutes.
Oct 5, 2020 The stock of MyoKardia (ticker: MYOK) leapt 59% to $220.34, after it agreed another biotech company with cardiac treatments in clinical trials.
For all future releases Just for the upcoming release 2020-10-05 · None have rated the stock as Underweight. The expected earnings per share for the stock is -$1.47. MyoKardia, Inc. (NASDAQ:MYOK) trade information. Sporting 58.02% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Oct 05 when the MYOK stock price touched $224 or saw a rise of 1.4%. MyoKardia, Inc. is a clinical-stage biopharmaceutical company.
On Tuesday, Bristol Myers Squibb (NYSE: BMY) announced that its buyout of heart medication specialist MyoKardia has been finalized; the latter company is now a fully owned subsidiary, with its Company profile page for MyoKardia Inc including stock price, company news, press releases, executives, board members, and contact information Find the latest historical data for MyoKardia, Inc. Common Stock (MYOK) at Nasdaq.com. Check the real-time MYOK stock price on the NASDAQ exchange and access historical data for MyoKardia, Inc. stock. Instantly find out the MyoKardia, Inc. stock quote Get MyoKardia Inc (MYOK-MX:undefined) real-time stock quotes, news, price and financial information from CNBC. MyoKardia NASDAQ Updated Apr 14, 2021 12:00 AM. MYOK 0.00 0.00 (0.00%).